A randomised controlled trial (RCT) to assess the incremental costs and clinical benefits of cognitive analytic therapy (CAT) to standard care within community mental health teams in the treatment of severe personality disorder

HS R&D Regional Programme Register - Department of Health (UK)0 个研究点目标入组 48 人开始时间: 2004年1月23日最近更新: 2020年1月6日

试验速览

暂无简介。

•48 'hard to treat' mental health service users with complex mental health problems who have been in active contact with the participating trusts for at least one year and whose major presenting problems have not been successfully treated.
•1. A diagnosis of Cluster B Personality Disorder (Diagnostic and Statistical Manual of Mental Disorders, fourth edition [DSM IV], Axis II - as per Million Clinical Multiaxial Inventory III [MCMI III])
•2. A Beck Depression Index score above 25
•3. One year (or longer) history of unsuccessful treatment (assessed by case note review by the responsible medical officers [RMOs]); or at least two hospital admissions in the past 5 years following parasuicide.
•4. Still on active caseload of Community Mental Health Team (CMHT) (Care Programme Approach [CPA] level 1 or higher).

•1. Concurrent organic or definite psychotic illness (though patients suffering micropsychotic episodes only will not be excluded)
•2. Referral to CAT services in past five years
•3. Currently receiving another formal psychological treatment
•4. Current admission to inpatient care (though subsequent admission during the course of the trial will not exclude patients from further follow-up)
•5. Current active substance abuse (including alcohol)

发起方

HS R&D Regional Programme Register - Department of Health (UK)